Driehaus Capital Management’s Legend Biotech LEGN Stock Holding History

Driehaus Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.5M	Buy	+1,158,808	New	+$31.3M	0.19%	161
2024 Q1	–	Sell	-234,206	Closed	-$14.1M	–	419
2023 Q4	$14.1M	Buy	234,206 +28,103	+14%	+$1.78M	0.17%	197
2023 Q3	$13.8M	Buy	+206,103	New	+$14.3M	0.18%	167
2022 Q3	–	Sell	-317,117	Closed	-$17.4M	–	377
2022 Q2	$17.4M	Buy	+317,117	New	+$13.4M	0.28%	120
2020 Q3	–	Sell	-365,174	Closed	-$15.5M	–	421
2020 Q2	$15.5M	Buy	+365,174	New	+$14.3M	0.38%	78

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Driehaus Capital Management's LEGN Position: Q2 2026 in Review

Driehaus Capital Management opened a new position in Legend Biotech (LEGN) in Q2 2026: 1,158,808 shares worth $33.5M. The stake represents 0.19% of the portfolio and ranks #161 among its holdings. This is a return to the name: Driehaus Capital Management previously reported a position in LEGN as recently as Q4 2023.

Driehaus Capital Management first reported a position in LEGN in Q2 2020 and has held it in 5 quarters since. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Driehaus Capital Management held 1,158,808 shares of Legend Biotech worth $33.5M as of Q2 2026.
Legend Biotech was a new Driehaus Capital Management position in Q2 2026.
Legend Biotech made up 0.19% of Driehaus Capital Management's portfolio in Q2 2026, its #161 holding.
Driehaus Capital Management first reported a position in Legend Biotech in Q2 2020 and has held it in 5 quarters since.
219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.